These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 11281230

  • 1. Hormone replacement therapy increases plasma level of angiotensin II in postmenopausal hypertensive women.
    Umeda M, Ichikawa S, Kanda T, Sumino H, Kobayashi I.
    Am J Hypertens; 2001 Mar; 14(3):206-11. PubMed ID: 11281230
    [Abstract] [Full Text] [Related]

  • 2. Different effects of transdermal and oral hormone replacement therapy on the renin-angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women.
    Ichikawa J, Sumino H, Ichikawa S, Ozaki M.
    Am J Hypertens; 2006 Jul; 19(7):744-9. PubMed ID: 16814131
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin II plays an important role in maintaining blood pressure in postmenopausal women receiving hormone replacement therapy.
    Sumino H, Ichikawa S, Miya Y, Sakamaki T, Kurabayashi M.
    Am J Hypertens; 2005 Oct; 18(10):1340-6. PubMed ID: 16202859
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hormone replacement therapy in postmenopausal women with essential hypertension increases circulating plasma levels of bradykinin.
    Sumino H, Ichikawa S, Kanda T, Sakamaki T, Nakamura T, Sato K, Kobayashi I, Nagai R.
    Am J Hypertens; 1999 Oct; 12(10 Pt 1):1044-7. PubMed ID: 10560792
    [Abstract] [Full Text] [Related]

  • 6. Effects of long-term transdermal hormone replacement therapy on the renin-angiotensin- aldosterone system, plasma bradykinin levels and blood pressure in normotensive postmenopausal women.
    Ichikawa A, Sumino H, Ogawa T, Ichikawa S, Nitta K.
    Geriatr Gerontol Int; 2008 Dec; 8(4):259-64. PubMed ID: 19149837
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of hormone replacement therapy on left ventricular hypertrophy and growth-promoting factors in hypertensive postmenopausal women.
    Miya Y, Sumino H, Ichikawa S, Nakamura T, Kanda T, Kumakura H, Takayama Y, Mizunuma H, Sakamaki T, Kurabayashi M.
    Hypertens Res; 2002 Mar; 25(2):153-9. PubMed ID: 12047028
    [Abstract] [Full Text] [Related]

  • 10. Long-term effects of telmisartan on blood pressure, the renin-angiotensin-aldosterone system, and lipids in hypertensive patients.
    Aoki A, Ogawa T, Sumino H, Kumakura H, Takayama Y, Ichikawa S, Nitta K.
    Heart Vessels; 2010 May; 25(3):195-202. PubMed ID: 20512446
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of losartan on angiotensin and bradykinin peptides and angiotensin-converting enzyme.
    Campbell DJ, Kladis A, Valentijn AJ.
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):233-40. PubMed ID: 7475048
    [Abstract] [Full Text] [Related]

  • 13. Interruption of prolonged ramipril treatment in hypertensive patients: effects on the renin-angiotensin system.
    Stephan D, Grima M, Welsch M, Barthelmebs M, Vasmant D, Imbs J.
    Fundam Clin Pharmacol; 1996 Aug; 10(5):474-83. PubMed ID: 8902551
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Serum angiotensin-converting enzyme 2 concentration and angiotensin-(1-7) concentration in patients with acute heart failure patients requiring emergency hospitalization.
    Hisatake S, Kiuchi S, Kabuki T, Oka T, Dobashi S, Ikeda T.
    Heart Vessels; 2017 Mar; 32(3):303-308. PubMed ID: 27421979
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Circulating renin Angiotensin system in childhood chronic renal failure: marked increase of Angiotensin-(1-7) in end-stage renal disease.
    Simões e Silva AC, Diniz JS, Pereira RM, Pinheiro SV, Santos RA.
    Pediatr Res; 2006 Dec; 60(6):734-9. PubMed ID: 17065573
    [Abstract] [Full Text] [Related]

  • 19. Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme.
    Agata J, Ura N, Yoshida H, Shinshi Y, Sasaki H, Hyakkoku M, Taniguchi S, Shimamoto K.
    Hypertens Res; 2006 Nov; 29(11):865-74. PubMed ID: 17345786
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.